Published in J Clin Endocrinol Metab on March 01, 2009
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80
A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet (1998) 4.13
A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet (1998) 4.06
Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med (2008) 2.86
Monogenic obesity in humans. Annu Rev Med (2005) 2.53
Multiple sclerosis. Immunol Rev (2005) 1.92
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (2005) 1.72
Unraveling the genetics of human obesity. PLoS Genet (2006) 1.63
Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab (2008) 1.49
Neuropeptide processing and its impact on melanocortin pathways. Endocrinology (2007) 1.28
Monogenic human obesity. Front Horm Res (2008) 1.19
Proteomics technologies for the study of autoimmune disease. Arthritis Rheum (2002) 0.98
New insights into the genetics of body weight. Curr Opin Clin Nutr Metab Care (2008) 0.90
Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. J Clin Endocrinol Metab (2007) 0.89
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol (2007) 0.85
Antibodies as pharmacologic tools for studies on the regulation of energy balance. Nutrition (2008) 0.83
Anti-melanocortin-4 receptor autoantibodies in obesity. J Clin Endocrinol Metab (2008) 0.83
Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents. J Endocrinol Invest (2006) 0.82
Novel melanocortin 4 receptor gene mutations in severely obese children. Clin Endocrinol (Oxf) (2007) 0.80
The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci U S A (2007) 3.11
Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science (2006) 2.58
Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity (2008) 2.48
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2009) 2.31
Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case. Hepatobiliary Pancreat Dis Int (2007) 1.93
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol (2012) 1.93
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med (2009) 1.80
Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab (2009) 1.79
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. Kidney Int (2011) 1.72
Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta (2009) 1.63
Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum (2003) 1.63
Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum (2007) 1.62
Toll-like receptor signaling pathways--therapeutic opportunities. Mediators Inflamm (2010) 1.58
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest (2009) 1.54
Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun (2009) 1.51
Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol (2007) 1.49
Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum (2012) 1.48
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest (2005) 1.45
Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol (2004) 1.34
Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy. J Clin Endocrinol Metab (2003) 1.33
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25
Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol (2007) 1.22
Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med (2004) 1.22
Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J Exp Med (2002) 1.22
CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol (2009) 1.22
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol (2007) 1.21
A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS. Hum Mutat (2006) 1.20
Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem Biophys Res Commun (2005) 1.20
Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum (2003) 1.18
Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2011) 1.17
Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am J Med Genet A (2010) 1.15
Metabolic disturbances associated with systemic lupus erythematosus. PLoS One (2012) 1.15
Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest (2007) 1.14
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum (2006) 1.14
Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol (2006) 1.13
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther (2012) 1.10
Primary isolated extramedullary plasmacytoma of colon. World J Surg Oncol (2007) 1.09
Squamous variant of gallbladder cancer: is it different from adenocarcinoma? Am J Surg (2013) 1.08
Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metab (2009) 1.08
Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther (2011) 1.05
Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol (2009) 1.04
Macrophage subpopulations in systemic lupus erythematosus. Discov Med (2012) 1.02
Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol (2013) 1.00
Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One (2011) 0.99
Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol (2010) 0.99
Functional characterization of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 10/glycerol-3-phosphate acyltransferase isoform 3. J Mol Endocrinol (2009) 0.98
A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia. J Clin Endocrinol Metab (2005) 0.98
Proteomic toolbox for autoimmunity research. Autoimmun Rev (2009) 0.98
Lupus nephritis: current update. Arthritis Res Ther (2011) 0.97
Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet A (2008) 0.97
The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections. J Immunol (2006) 0.97
Caveolin-1: a new locus for human lipodystrophy. J Clin Endocrinol Metab (2008) 0.96
Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care (2003) 0.96
Evaluation of the POSSUM scoring system for comparative audit in pancreatic surgery. Dig Surg (2003) 0.95
Ultrasound guided fine needle aspiration cytology in the diagnosis of retroperitoneal masses: A study of 85 cases. J Cytol (2009) 0.95
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum (2010) 0.95
The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol (2009) 0.95
Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells. Biochem Biophys Res Commun (2007) 0.95
Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress. PLoS One (2013) 0.95
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus. Expert Opin Ther Targets (2009) 0.94
Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis. Arch Immunol Ther Exp (Warsz) (2008) 0.94
The lupus-prone NZM2410/NZW strain-derived Sle1b sublocus alters the germinal center checkpoint in female mice in a B cell-intrinsic manner. J Immunol (2012) 0.94
Enhanced egg-induced immunopathology correlates with high IFN-gamma in murine schistosomiasis: identification of two epistatic genetic intervals. J Immunol (2005) 0.93
Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol (2011) 0.93
Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum (2005) 0.93
Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus. Arthritis Res Ther (2012) 0.92
PI3K/AKT signaling and systemic autoimmunity. Immunol Res (2005) 0.92
What do mouse models teach us about human SLE? Clin Immunol (2006) 0.92
SLE 1, 2, 3...genetic dissection of lupus. Adv Exp Med Biol (2007) 0.92
Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol (2006) 0.92
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res (2011) 0.91
Xanthogranulomatous cholecystitis: a premalignant condition? Hepatobiliary Pancreat Dis Int (2011) 0.91
Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation. J Clin Endocrinol Metab (2005) 0.91
A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model (2008) 0.91
Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther (2012) 0.90
Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics (2013) 0.90
The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets (2009) 0.90
Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol (2002) 0.89
Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol (2010) 0.89
PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr. Int Immunol (2007) 0.88
Isolated Roux Loop duct-to-mucosa pancreaticojejunostomy avoids pancreatic leaks in pancreaticoduodenectomy. Dig Surg (2002) 0.88
Hepatic gluconeogenesis is enhanced by phosphatidic acid which remains uninhibited by insulin in lipodystrophic Agpat2-/- mice. J Biol Chem (2014) 0.88
A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features. J Clin Endocrinol Metab (2005) 0.88
Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice. Am J Physiol Renal Physiol (2010) 0.88
Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire. Mol Immunol (2009) 0.87
Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone. Biochem Biophys Res Commun (2004) 0.87
Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrob Agents Chemother (2010) 0.87
Molecular signatures of antinuclear antibodies-contributions of heavy chain CDR residues. Mol Immunol (2002) 0.87
Diaphragm disease of the ileum: a case report. Trop Gastroenterol (2006) 0.87
IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol (2012) 0.87
Enzymatic activities of the human AGPAT isoform 3 and isoform 5: localization of AGPAT5 to mitochondria. J Lipid Res (2010) 0.86
Iatrogenic graft to vein fistula (GVF) formation associated with synthetic arteriovenous grafts. Semin Dial (2010) 0.85
Strain distribution pattern of immune nephritis--a follow-up study. Int Immunol (2008) 0.85
CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis. Arthritis Rheum (2007) 0.85
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus. J Immunol (2013) 0.85
Altered B-cell signaling in lupus. Autoimmun Rev (2008) 0.84
Haemoperitoneum caused by perforation of Meckel's diverticulum in a 5-year-old child. BMJ Case Rep (2010) 0.84